General form of registration statement for all companies including face-amount certificate companies

Stock-Based Compensation (Tables)

v3.20.2
Stock-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of RSA activity

 

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair Value

 

Unvested, December 31, 2019

 

 

450,000

 

 

$ 0.19

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

Released

 

 

(450,000 )

 

 

0.19

 

Unvested, March 31, 2020

 

 

 

 

$

 

 
Stock options | Omnibus Incentive Plan 2014    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of shares available for future grant  

 

 

Shares Available for Grant

 

Available as of December 31, 2018

 

 

9,142,273

 

Share pool increase

 

 

4,898,750

 

Forfeited

 

 

153,125

 

Cancelled

 

 

196,875

 

Granted

 

 

(1,262,642 )

Available as of December 31, 2019

 

 

13,128,381

 

Schedule of summary of stock option activity  

 

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average Remaining

Contractual

Term

(Years)

 

 

Aggregate Intrinsic Value*

 

Outstanding, December 31, 2018

 

 

2,405,000

 

 

$ 0.33

 

 

 

8.71

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

1,262,642

 

 

 

0.30

 

 

 

 

 

 

 

 

Cancelled

 

 

(196,875 )

 

 

0.26

 

 

 

 

 

 

 

 

Forfeited

 

 

(153,125 )

 

 

0.26

 

 

 

 

 

 

 

 

Outstanding, December 31, 2019

 

 

3,317,642

 

 

$ 0.33

 

 

 

8.34

 

 

$

 

Exercisable, December 31, 2019

 

 

2,399,356

 

 

$ 0.34

 

 

 

7.84

 

 

$

 

Vested and expected to vest, December 31, 2019

 

 

3,317,642

 

 

$ 0.33

 

 

 

8.34

 

 

$

 

 

*The aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the stock options at December 31, 2019 for those stock options for which the quoted market price was in excess of the exercise price (“in-the-money options”).

Schedule of fair value assumptions of stock option granted  

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

Dividend yield

 

 

0.00 %

 

 

0.00 %

Risk-free interest rate

 

 

1.49 %

 

 

3.06—3.10

%

Expected term (years)

 

 

5.65

 

 

 

5.27—5.58

 

Volatility

 

 

93.72 %

 

 

70.00—93.60

%

Stock options | Awards Granted Outside the 2014 Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of fair value assumptions of stock option granted  

 

 

 

At Issuance

 

Dividend Yield

 

 

0.00

%

Risk-free interest rate

 

 

2.79 %

Expected term (in years)

 

 

5.54

 

Volatility

 

 

70 %
Restricted Stock Awards | Awards Granted Outside the 2014 Plan    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of RSA activity  

 

 

Number of

Shares

 

 

Weighted

Average Grant

Date Fair Value

 

Unvested, December 31, 2018

 

 

900,000

 

 

$ 0.19

 

 

 

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

Released

 

 

(450,000 )

 

 

0.19

 

Unvested, December 31, 2019

 

 

450,000

 

 

$ 0.19